Letter: metabolic dysfunction-associated fatty liver disease increases risk of all-cause mortality in patients with chronic hepatitis C

被引：0
|
作者：
Zhao, Qianwen [1 ]
Deng, Yunlei [2 ]
机构：
[1] Sichuan Univ, Sichuan Univ Univ Oxford Huaxi Joint Ctr Gastroint, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Peoples R China
[2] Southwest Jiaotong Univ, Peoples Hosp 3, Dept Nephrol, Affiliated Hosp, 82 Qinglong St, Chengdu 610031, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 02期
关键词：
D O I：
10.1111/apt.17294
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Attia et al paper. To view this article, visit
引用
收藏
页码：272 / 273
页数：2
相关论文
共 50 条
  • [21] Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms
    He, Yuan
    Duan, Zhi-Jun
    Wang, Cheng-Fang
    Wei, Yu-Shan
    Cai, Ming-Xu
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 199 - 207
  • [22] Risk of all-cause and cardiovascular mortality in patients with chronic liver disease
    Targher, Giovanni
    Zoppini, Giacomo
    Day, Christopher P.
    GUT, 2011, 60 (11) : 1602 - 1603
  • [23] Association of life's essential 8 with all-cause and cause-specific mortality in metabolic dysfunction-associated steatotic liver disease
    Li, Xiang
    Zhang, Yi
    Gong, Junyi
    Ni, Xiang
    Yin, Junli
    Lv, Zheng
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Association of High-Sensitivity Troponins in Metabolic Dysfunction-Associated Steatotic Liver Disease With All-Cause and Cause-Specific Mortality
    Kim, Donghee
    Danpanichkul, Pojsakorn
    Wijarnpreecha, Karn
    Cholankeril, George
    Ahmed, Aijaz
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [25] LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease
    Leow, Yong Wen
    Chan, Wah Loong
    Lai, Lee Lee
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    Quiambao, Ronald
    Munteanu, Mona
    Chan, Wah Kheong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (10) : 2182 - 2189
  • [26] Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
    Wang, Xiaolin
    Xie, Qing
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (01) : 128 - 133
  • [27] Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors
    Del Barrio Azaceta, Maria
    Iruzubieta, Paula
    Aller De La Fuente, Rocio
    Maria Banales, Jesus
    Santos-Laso, Alvaro
    Calleja Panero, Jose Luis
    Ibanez, Luis
    Arias Loste, Maria Teresa
    Romero Gomez, Manuel
    Garcia-Monzon, Carmelo
    Gomez-Camarero, Judith
    Gines, Pere
    Morillas, Rosa M.
    Manuel Pericas, Juan
    Aspichueta, Patricia
    Martin-Mateos, Rosa
    Gallego-Duran, Rocio
    De La Torre Sanchez, Mercedes
    Escudero-Garcia, Desamparados
    Bernal Monterde, Vanesa
    Benlloch, Salvador
    Turnes, Juan
    Crespo, Javier
    JOURNAL OF HEPATOLOGY, 2022, 77 : S157 - S157
  • [28] Risk of all-cause and cardiovascular mortality in patients with chronic liver disease Reply
    Stepanova, Maria
    Younossi, Zobair M.
    GUT, 2011, 60 (11) : 1603 - 1604
  • [29] Metabolic dysfunction-associated steatotic liver disease increases hepatocellular carcinoma risk in chronic hepatitis B patients: a retrospective cohort study
    Lin, Ming
    Gao, Bowen
    Peng, Mengnan
    Chen, Xuefang
    Xiao, Huanming
    Shi, Meijie
    Zhang, Xiujuan
    Zeng, Folai
    Chi, Xiaoling
    FRONTIERS IN PHYSIOLOGY, 2024, 15
  • [30] Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease
    Nakamura, Koshi
    Nakagawa, Hideaki
    Murakami, Yoshitaka
    Kitamura, Akihiko
    Kiyama, Masahiko
    Sakata, Kiyomi
    Tsuji, Ichiro
    Miura, Katsuyuki
    Ueshima, Hirotsugu
    Okamura, Tomonori
    KIDNEY INTERNATIONAL, 2015, 88 (05) : 1144 - 1152
12345